Tenaya Therapeutics与Alnylam Pharmaceuticals达成研究合作,共同探索心血管疾病治疗新靶点

美股速递
Mar 05

Tenaya Therapeutics Inc(简称Tenaya)已与Alnylam Pharmaceuticals(简称Alnylam)正式签署一项研究合作协议。双方将携手致力于识别并验证针对心血管疾病治疗的新型遗传靶点,旨在推动相关疗法研发取得突破性进展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10